| SBFMW Stock | | | USD 0.17 0.04 19.05% |
Sunshine Biopharma financial indicator trend analysis is much more than just breaking down Sunshine Biopharma prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sunshine Biopharma is a good investment. Please check the relationship between Sunshine Biopharma Cost Of Revenue and its Other Operating Expenses accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
For more information on how to buy Sunshine Stock please use our
How to Invest in Sunshine Biopharma guide.
Cost Of Revenue vs Other Operating Expenses
Cost Of Revenue vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Sunshine Biopharma Cost Of Revenue account and
Other Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Sunshine Biopharma's Cost Of Revenue and Other Operating Expenses is 0.98. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Sunshine Biopharma Warrant, assuming nothing else is changed. The correlation between historical values of Sunshine Biopharma's Cost Of Revenue and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Sunshine Biopharma Warrant are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Cost Of Revenue i.e., Sunshine Biopharma's Cost Of Revenue and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.98 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Cost Of Revenue
Cost of Revenue is found on Sunshine Biopharma income statement and represents the costs associated with goods and services Sunshine Biopharma provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sunshine Biopharma. It is also known as Sunshine Biopharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from Sunshine Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sunshine Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
For more information on how to buy Sunshine Stock please use our
How to Invest in Sunshine Biopharma guide.At this time, Sunshine Biopharma's
Selling General Administrative is fairly stable compared to the past year.
Tax Provision is likely to climb to about 428.6
K in 2024, despite the fact that
Issuance Of Capital Stock is likely to grow to (8.6
M).
| 2021 | 2022 | 2023 | 2024 (projected) |
Other Operating Expenses | 2.7M | 13.0M | 28.9M | 30.3M | Interest Expense | 328.8K | 39.4K | 137.3K | 148.9K |
Sunshine Biopharma fundamental ratios Correlations
Click cells to compare fundamentals
Sunshine Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sunshine Biopharma fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Sunshine Stock Analysis
When running Sunshine Biopharma's price analysis, check to
measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to
predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.